contezolid: Clinical Trials

6 trials of contezolid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 enrolling by invitation, 2 recruiting, 1 active not recruiting. 3 Phase 2, 2 Phase 1, 2 Phase 4, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Enrolling by invitation 3
Phase 12Enrolling by invitation 2
Phase 42Recruiting 2
Phase 31Active not recruiting 1

Follow contezolid: new trials by email Literature Review of contezolid trials Research Report on contezolid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease
Contezolid, linezolid - Monotherapy, Mycobacterium Abscessus Infection
Phase 2Enrolling by invitationBeijing Chest Hospital242026-01-012026-01-28
Short-term Bactericidal Effect of Contezolid in MAC-PD
Contezolid, Azithromcyin, Rifampicin (RIF) - Mycobacterium Avium Complex Pulmonary Disease
Phase 4RecruitingBin Cao1882025-07-242025-09-18
Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease
Contezolid, Azithromycin, Ethambutol (E) - Mycobacterium Avium Complex Pulmonary Disease
Phase 4RecruitingBin Cao1882025-07-242025-10-09
Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis
Contezolid, Linezolid (LZD) - Tuberculosis, Meningitis
Phase 1 / Phase 2Enrolling by invitationBeijing Chest Hospital242024-02-012025-02-06
Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis
Contezolid, Linezolid (LZD) - Tuberculosis, Bone
Phase 1 / Phase 2Enrolling by invitationBeijing Chest Hospital242024-01-312025-02-06
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis:Contezolid, Delamanid and Bedaquiline Cohort
Bedaquiline, Delamanid, Contezolid - Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
Phase 3Active not recruitingBeijing Chest Hospital1862023-12-222025-04-01

Conditions studied

Tuberculosis (3)  ·  Meningitis (1)  ·  Mycobacterium Infections, Nontuberculous (1)  ·  Tuberculosis, Meningeal (1)  ·  Tuberculosis, Pulmonary (1)

Sponsors

Beijing Chest Hospital (4)  ·  Bin Cao (2)

Countries

China (6)

Top investigators

Wenjuan Nie, Director (1)  ·  Xiaojin Cui, M.D. (1)  ·  Xiaojing Cui, M.D. (1)